List of companies in British Patient Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Ultraleap is a developer of mid-air haptics, 3D hand tracking, and gesture recognition technologies intended to enable a shift toward spatial three-dimensional interfaces. | ||||||
Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen. | ||||||
An artificial intelligence company that is developing the technology to automate computer numerical control milling machines. It is located in London, England and was founded in 2015. | ||||||
Form3 is a cloud-native account-to-account payments platform founded in 2016 by Michael Mueller. | ||||||
Quantexa is a company that enables institutions to make better decisions using their data. | ||||||
Thought Machine is a fintech company that builds cloud-based platforms for the banking industry. | ||||||
Proximie is a technology company that enables clinicians to virtually catch up with lab from anywhere in the world. | ||||||
Purespring Therapeutics is a gene therapy provider for kidney diseases founded in 2020. | ||||||
CyberSmart is a London-based cybersecurity company developing automated compliance platform for small to medium enterprises. | ||||||
Microbiotica Limited is a gut Bacteria Phenotype to Biomarker/Therapeutics founded in 2016 by Mike Romanos. | ||||||
Paragraf is a manufacturer of graphene-based electronic devices founded in 2017. | ||||||
Nucleome Therapeutics technology uses novel molecular biology techniques that define the 3D structure of the genome and computational genomics powered by machine learning to help deliver the next generation of genetically guided therapeutics. | ||||||
Developer of neurostimulation system to treat swallowing dysfunction. | ||||||
Developer of immunoglobulin E (IgE) antibodies to treat cancer. | ||||||
Contextual decision intelligence platform for the public and private sectors. | ||||||
Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases. | ||||||
Curve Therapeutics Limited is an intracellular screening platform founded in 2019. | ||||||
Tenpoint Therapeutics is a restore sight by replacing engineered cell-based therapeutics founded in 2020. | ||||||
Tenpoint Therapeutics is a restore sight by replacing engineered cell-based therapeutics founded in 2020. |
